![Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/4dcbeea0-d1ac-4fc6-9a1d-4e40e9d1d7fa/gr2_lrg.jpg)
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV
![New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin | aidsmap New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_medium_crop/public/2020-03/paediatric-dosing-article.png?itok=lZqnGk_u)
New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin | aidsmap
![A single dose of ultra-LA dolutegravir protects against multiple high... | Download Scientific Diagram A single dose of ultra-LA dolutegravir protects against multiple high... | Download Scientific Diagram](https://www.researchgate.net/publication/328147212/figure/fig4/AS:958879806550024@1605626169280/A-single-dose-of-ultra-LA-dolutegravir-protects-against-multiple-high-dose-HIV-1.png)
A single dose of ultra-LA dolutegravir protects against multiple high... | Download Scientific Diagram
![KIEV, UKRAINE - September 25, 2019: Dolutegravir / Lamivudine is the First Two-component Drug in a Fixed Dosage, Which is a Comple Editorial Image - Image of complex, editorial: 158426830 KIEV, UKRAINE - September 25, 2019: Dolutegravir / Lamivudine is the First Two-component Drug in a Fixed Dosage, Which is a Comple Editorial Image - Image of complex, editorial: 158426830](https://thumbs.dreamstime.com/b/kiev-ukraine-september-dolutegravir-lamivudine-first-two-component-drug-fixed-dosage-which-comple-complete-treatment-158426830.jpg)
KIEV, UKRAINE - September 25, 2019: Dolutegravir / Lamivudine is the First Two-component Drug in a Fixed Dosage, Which is a Comple Editorial Image - Image of complex, editorial: 158426830
![Figure 2 from Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. | Semantic Scholar Figure 2 from Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2ebaaf62e2b7565bda347ab2b3c11ae21e0fe00a/4-Figure2-1.png)
Figure 2 from Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. | Semantic Scholar
![Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans | Antimicrobial Agents and Chemotherapy Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00292-13/asset/3703e98b-e5bb-4d2f-b10d-d176b3a2b90a/assets/graphic/zac9991019880006.jpeg)
Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans | Antimicrobial Agents and Chemotherapy
![Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - ScienceDirect Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352301820301892-gr3.jpg)
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - ScienceDirect
![PDF) Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial PDF) Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial](https://i1.rgstatic.net/publication/343434086_Simplified_dolutegravir_dosing_for_children_with_HIV_weighing_20_kg_or_more_pharmacokinetic_and_safety_substudies_of_the_multicentre_randomised_ODYSSEY_trial/links/5f47f0de299bf13c5040abf7/largepreview.png)